Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
1993-12-10
|
pubmed:abstractText |
Activation of T cell hybridomas through their TCR leads to secretion of IL-2, inhibition of proliferation, and apoptosis. The identification of various inhibitors that prevent activation-induced T cell death (AICD) has helped identify several essential events in apoptosis. For example, inhibition of AICD by dexamethasone indicates a connection between these two programmed death pathways. In this study, we have investigated the interaction between the cAMP signal transduction pathway and the activation- or glucocorticoid-induced cell death. cAMP induced DNA fragmentation in thymocytes. T cell hybridomas displayed different sensitivity to cAMP. Regardless of its cAMP sensitivity, programmed cell death promoted by anti-CD3 or Ag in hybridoma was prevented by the presence of cAMP analogs. In contrast, cAMP had no effect on glucocorticoid-induced T cell death. The inhibitory effect of cAMP on AICD was unlikely to be due to quenching of T cell activation signals, because cAMP added 1 h after T cell activation could still prevent cell death. In addition, the increased binding of AP-1, NF-AT, and NF-kappa B during T cell activation was not significantly affected by cAMP. The presence of the inhibitory cAMP-mediated signals, together with the glucocorticoid-induced pathway, suggest there are at least two distinct mechanisms regulating AICD in immature lymphocytes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Bucladesine,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclic AMP,
http://linkedlifedata.com/resource/pubmed/chemical/DNA,
http://linkedlifedata.com/resource/pubmed/chemical/Dexamethasone,
http://linkedlifedata.com/resource/pubmed/chemical/Forskolin,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
151
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5208-17
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8228219-Amino Acid Sequence,
pubmed-meshheading:8228219-Apoptosis,
pubmed-meshheading:8228219-Base Sequence,
pubmed-meshheading:8228219-Bucladesine,
pubmed-meshheading:8228219-Cell Line,
pubmed-meshheading:8228219-Cyclic AMP,
pubmed-meshheading:8228219-DNA,
pubmed-meshheading:8228219-Dexamethasone,
pubmed-meshheading:8228219-Forskolin,
pubmed-meshheading:8228219-Genes, myc,
pubmed-meshheading:8228219-Hybridomas,
pubmed-meshheading:8228219-Lymphocyte Activation,
pubmed-meshheading:8228219-Molecular Sequence Data,
pubmed-meshheading:8228219-T-Lymphocytes,
pubmed-meshheading:8228219-Transcription Factors
|
pubmed:year |
1993
|
pubmed:articleTitle |
cAMP analogs prevent activation-induced apoptosis of T cell hybridomas.
|
pubmed:affiliation |
Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan, R.O.C.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|